Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for TEPLIZUMAB
- Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
- A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
- Efficacy and Safety of Teplizumab in Japanese Participants With Stage 2 Type 1 Diabetes
- GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab
- Effects of Sitagliptin in Relatives of T1D Patients
- A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recently Diagnosed Type 1 Diabetes Mellitus (T1D)
- Subcutaneous Administration of Teplizumab in Adults With Type 1 Diabetes
- Teplizumab for Prevention of Type 1 Diabetes In Relatives "At-Risk"
- Protege Encore Study- Clinical Trial of Teplizumab (MGA031) in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
- Protege Extension Trial - Long Term Follow Up Trial for Subjects Who Completed the Protege Study (CP-MGA031-01)
- Treatment With hOKT3gamma1(Ala-Ala) in T1DM
- The Protégé Study - Clinical Trial of MGA031 in Children and Adults With Recent-Onset Type 1 Diabetes Mellitus
- Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes
Clinical trials list
click for details